Published in Clinical Oncology Week, January 22nd, 2007
"To explore the potential role and the prognostic value of leptin receptor (Ob-R) in HCC. 66 patients with pathologically confirmed HCC were included in this study. Immunohistochemistry was used to evaluate the expression of Ob-R, microvessel density (MVD) and Ki-67 index in these patients. Eventually, the profiles of Ob-R expression,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week